Becton Dickinson And Company Stock News

Highland Capital Management LLC trimmed its holdings in Becton, Dickinson and Company (NYSE:BDX) by 2.6% in the third quarter, Holdings Channel reports. The fund owned 18,422 shares of the medical instruments suppliers stock after selling 490 shares during the period. Highland Capital Management LLCs holdings in Becton, Dickinson and were worth $4,528,000 at the end []

Wedgewood Investors Inc. PA lowered its stake in Becton, Dickinson and Company (NYSE:BDX) by 2.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 2,521 shares of the medical instruments suppliers stock after selling 58 shares during the quarter. Wedgewood Investors Inc. PAs holdings in Becton, Dickinson and were worth $620,000 as of []

BD's (BDX) latest acquisition is expected to complement its currently used products and help to support minimally invasive surgeries.

Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. Global Respiratory Trainer

The Genomics and Proteomics Reagents, Research Kits, & Analytical Instrumentation Market covers the present scenario (with the base year being 2021) and the growth prospects of global Genomics and Proteomics Reagents, Research Kits, & Analytical Instrumentation market for 20212028. The

NEW YORK, Dec. 10, 2021 /PRNewswire/ -- The global laboratory consumables primary packaging market is fragmented with the presence of several global and regional players. Prominent players in the market are focusing on developing advanced and high-quality products with enhanced durability

Crossmark Global Holdings Inc. increased its position in Becton, Dickinson and Company (NYSE:BDX) by 0.3% in the third quarter, Holdings Channel.com reports. The firm owned 13,204 shares of the medical instruments suppliers stock after acquiring an additional 46 shares during the period. Crossmark Global Holdings Inc.s holdings in Becton, Dickinson and were worth $3,246,000 at []

The 32 Dividend Kings lost 1.68% in November, underperforming the broad market once more this year.

Published on December 8th, 2021 by Bob Ciura Becton, Dickinson & Company (BDX) recently increased its dividend for the 50th consecutive years. As a result, it has joined the exclusive list of Dividend Kings. The Dividend Kings have raised their dividend payouts for at least 50 consecutive years. You can see all 35 Dividend Kings [] The post Dividend Kings In Focus: Becton, Dickinson & Company appeared first on Sure Dividend .

Pensioenfonds Rail & OV cut its stake in Becton, Dickinson and Company (NYSE:BDX) by 9.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 444,839 shares of the medical instruments suppliers stock after selling 46,341 shares during the quarter. Becton, Dickinson and makes []

Allen Capital Group LLC lessened its position in Becton, Dickinson and Company (NYSE:BDX) by 37.1% during the 3rd quarter, Holdings Channel reports. The firm owned 2,422 shares of the medical instruments suppliers stock after selling 1,429 shares during the quarter. Allen Capital Group LLCs holdings in Becton, Dickinson and were worth $595,000 at the end []

Graybill Bartz & Assoc Ltd. boosted its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,641 shares of the medical instruments suppliers stock after buying an additional 329 shares during the quarter. Becton, []

Farmers & Merchants Investments Inc. trimmed its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 2.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,852 shares of the medical instruments suppliers stock after selling 577 shares during the period. []

Becton, Dickinson and (NYSE:BDX) was downgraded by Piper Sandler from an overweight rating to a neutral rating in a research note issued to investors on Wednesday, The Fly reports. They presently have a $260.00 price target on the medical instruments suppliers stock, down from their previous price target of $285.00. Piper Sandlers target price indicates []

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.